Novanta Inc.

NOVT

CIK 0001076930 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$258M
↑+8.5% +$20Mvs FY2024 (Q4)
Operating Income
$25M
↓-7.0% -$2Mvs FY2024 (Q4)
Net Income
$17M
↑+6.1% +$1Mvs FY2024 (Q4)
Gross Profit
$113M
↑+4.7% +$5Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
48/100
  • Profitability
    2ROIC 5.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.69 (above 1.5 = solid)
  • Leverage
    92D/E 0.16 (under 0.5 = conservative)
  • Efficiency
    32Asset Turnover 0.61x (1.0+ = capital-efficient)
  • Growth
    45Revenue YoY +8.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    17Op Margin 9.6% · trend -2.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project NOVT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -12.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$18.42
Total enterprise IV
$676M
Diluted shares
0.04B
Terminal PV
$476M (70% of total)
Year-5 FCF
$56M
YearProjected FCFDiscounted PV
+1$50M$45M
+2$51M$42M
+3$53M$40M
+4$55M$37M
+5$56M$35M
Terminal$767M$476M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$16M
investment in PP&E
Stock buybacks (TTM)
$39M
share count reduction
Stock-based comp (TTM)
$30M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.81B
everything owned
Total liabilities
$493M
everything owed
Stockholders' equity
$1.31B
shareholder claim
Net debt
$-168M
Net cash position ($168M)

Recent performance · 63 quarters

Revenue↑+8.5% +$20M
$258M
Net Income↑+6.1% +$1M
$17M
Free Cash Flow↓-91.3% -$54M
$5M
Operating Margin↓-1.6pts
9.6%

Drill down